Sat, Jan 31, 2015, 9:28 AM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Sarepta Therapeutics, Inc. Message Board

sam1423 1 post  |  Last Activity: Dec 4, 2014 10:51 AM Member since: Apr 29, 2010
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • sam1423@sbcglobal.net by sam1423 Dec 4, 2014 10:51 AM Flag

    Last year today PTCT stock = $16+ vs. SRPT stock = $18+... Fast forward to today's PTCT's = $48+. Additionally, "Credit Suisse has a risk adjusted price target of $66. Also assuming positive Phase 3 data in DMD, the company would be worth substantially more as a stand-alone or potential take out." Currently SRPT remains @ $15+ starting its Phase 3 and still...the future remains unknown...definitely I can smell a hostile takeover soon...Thanks to FDA!

SRPT
12.00-0.30(-2.44%)Jan 30 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.